Instructions for CITOVIR-3
Form of release:
Composition Pharmaco-therapeutic group Pharmacological properties Overdose Indications for use Method of application
Structure CITOVIR-3:
1 ml contains ascorbic acid 12 mg, bendazole 1.25 mg, sodium thymogen 150 mcg;
excipients: sucrose, purified water
Pharmaco-therapeutic group CITOVIR-3:
Immunostimulating agent.
Pharmacological properties CITOVIR-3:
Tsitovir is a complex immunomodulating drug CITOVIR-3 syrup intended for the prevention and early pathogenetic treatment of influenza and other acute respiratory viral infections (ARVI). It has an antiviral, immunomodulatory effect.
Bendazole, which is part of the drug, induces the production of endogenous interferon in the body. Enzymes induced by interferon in the cells of various organs inhibit viral replication. In addition, by activating immunocompetent cells, the drug helps to normalize the immune status.
Thymogen sodium acts on the T-cell link of immunity.
Ascorbic acid activates the humoral link of immunity, normalizes capillary permeability, thereby suppressing the inflammatory process.
Overdose CITOVIR-3:
Overdose cases are not described.
Indications for use CITOVIR-3:
prevention and complex therapy of influenza and ARVI in adults and children from 1 year old.
Mode of application CITOVIR-3 syrup:
Inside, 30 minutes before meals.
For prevention
With direct contact with a patient with influenza and other acute respiratory viral infections:
for children from 1 to 3 years old - 2 ml of solution 3 times / day;
for children from 3 to 6 years old - 4 ml 3 times / day; children from 6 to 10 years old - 8 ml 3 times / day;
children over 10 years old - 12 ml 3 times / day.
The course of the drug is 4 days.
Preventive courses with the drug, if necessary, are repeated after 3 weeks (until the epidemic situation normalizes).
The drug CITOVIR-3 syrup should be taken only according to the route of administration and in the doses indicated in the instructions.
Contraindications CITOVIR-3:
hypersensitivity to drug components;
lactase deficiency, lactose intolerance, sucrase / isomaltase deficiency, glucose-galactose malabsorption;
pregnancy;
children's age up to 1 year.
If necessary, the patient should consult a doctor before taking the drug CITOVIR-3 syrup.
With care: with arterial hypotension, diabetes mellitus and intolerance to certain sugars, the patient should consult a doctor before taking the drug.
Side effects CITOVIR-3:
On the part of the cardiovascular system: possibly - a short-term decrease in blood pressure.
Allergic reactions: possibly urticaria (in such cases, the use of the drug is stopped and symptomatic treatment, antihistamines are prescribed).
If you experience any of the above or any other side effects, you should consult your doctor.
If these side effects worsen, you should inform your doctor.
special instructions CITOVIR-3:
The drug CITOVIR-3 syrup contains fructose, taking more than 2 weeks may cause damage to the teeth.
After a second course, it is recommended to control the concentration of glucose in the blood.
Information for patients with diabetes mellitus: 1 ml of the drug solution contains 20 mg of lactose and 366.6 mg of fructose (in a preparation without a flavoring agent or 366.2 mg of fructose in a preparation with a flavoring agent), which corresponds to 0.032 bread unit (XE).
Sugar content in single and daily doses of the drug
Influence on the ability to drive vehicles and mechanisms
The drug CITOVIR-3 syrup does not affect the ability to drive vehicles, work with moving mechanisms and engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.
Drug interactions CITOVIR-3:
The interaction of alpha-glutamyl-tryptophan with drugs has not been identified.
Bendazole prevents an increase in TPVR caused by the use of non-selective beta-blockers. Strengthens the hypotensive effect (lowering blood pressure) of antihypertensive and diuretic drugs. Phentolamine enhances the hypotensive effect of bendazole.
Ascorbic acid increases the concentration of tetracycline antibiotics and benzylpenicillin in the blood. Improves intestinal absorption of iron preparations. Reduces the effectiveness of heparin and indirect anticoagulants.
Acetylsalicylic acid (ASA), and oral contraceptives, fresh juices, and alkaline drinks reduce its absorption and absorption. With simultaneous use with ASA, the excretion of ascorbic acid in the urine increases and the excretion of ASA decreases. ASA reduces the absorption of ascorbic acid by about 30%. Ascorbic acid increases the risk of crystalluria when using drugs containing ASA and short-acting sulfonamides, slows down the excretion of acids by the kidneys, increases the excretion of drugs with an alkaline reaction (including alkaloids), and reduces the concentration in the blood of oral contraceptives.
Reduces the therapeutic effect of antipsychotics (neuroleptics) - phenothiazine derivatives, tubular reabsorption of amphetamine and tricyclic antidepressants. Barbiturates and primidone increase the excretion of ascorbic acid in the urine.
CITOVIR-3 syrup